Exploring the emerging science connecting metabolic dysfunction with mental health—and what insulin resistance, mitochondrial function, inflammation, nutrition, and lifestyle medicine can teach us about comprehensive, personalized healthcare.
What if some of the biological processes that influence metabolic health also contribute to mental health?
For decades, healthcare has frequently approached metabolic and psychiatric conditions through separate specialties.
Metabolic medicine investigates processes such as glucose regulation, insulin resistance, lipid metabolism, obesity, and cardiovascular risk.
Psychiatry focuses on the assessment and treatment of mental disorders involving mood, cognition, perception, and behavior.
Yet the brain is not metabolically separate from the rest of the body.
It depends on a continuous supply of energy, participates in hormonal regulation, responds to inflammatory signaling, and interacts with the gastrointestinal, cardiovascular, endocrine, and immune systems.
Consequently, disturbances in metabolic regulation may have implications extending beyond traditional measures of body weight, blood glucose, or cholesterol.
This relationship is the focus of an emerging field known as metabolic psychiatry.
In March 2026, researchers published a comprehensive review in Nature Mental Health titled Metabolic Psychiatry Targeting Metabolic Dysregulation in Mental Health.
The authors examined evidence connecting systemic and central metabolic dysfunction with psychiatric symptoms, illness severity, and broader health outcomes.
Their review explored insulin resistance, lipid dysregulation, mitochondrial function, inflammation, and several emerging interventions designed to influence metabolic pathways.
An earlier 2025 commentary in the same journal, Metabolic Psychiatry: Key Priorities for an Emerging Field, outlined the scientific questions and research challenges that must be addressed as this discipline develops.
Together, these publications describe an important change in perspective.
Rather than examining psychiatric conditions exclusively through symptoms, neurotransmitters, or psychological experiences, researchers are investigating how energy metabolism and whole-body physiology may contribute to mental health.
However, this does not mean psychiatric disorders are simply metabolic diseases.
Nor does it mean that changing someone's diet, blood glucose, or metabolic measurements will necessarily resolve a psychiatric condition.
The relationship is considerably more complex.
Metabolic psychiatry seeks to understand how metabolic health and mental health influence one another—and whether carefully targeted metabolic interventions can improve outcomes when integrated with established psychiatric care.
Although this field remains under development, its underlying principles offer valuable insights into the importance of comprehensive, interdisciplinary, and personalized healthcare.
1. What Is Metabolic Psychiatry?
Metabolic psychiatry is an emerging area of psychiatric research and clinical investigation focused on relationships between metabolic processes and mental health.
It examines how disturbances in energy regulation, insulin signaling, mitochondrial function, inflammatory activity, and other metabolic processes may interact with psychiatric conditions.
The field also investigates whether interventions targeting these pathways might improve mental health outcomes.
Its scope includes both systemic metabolism and metabolism within the central nervous system.
Systemic metabolism involves the biological processes through which the body obtains, stores, distributes, and uses energy.
These processes involve the liver, skeletal muscle, adipose tissue, gastrointestinal system, endocrine organs, and other tissues.
Brain metabolism involves the energetic demands of neurons and supporting cells, including the processes necessary for electrical signaling, neurotransmission, and maintaining normal cellular function.
Although these systems have different regulatory characteristics, they interact continuously.
The emerging field therefore considers psychiatric illness within a broader metabolic context.
It also recognizes that the relationship can operate in both directions.
Metabolic disorders may influence mental health, while psychiatric illness, chronic stress, lifestyle changes, and psychiatric medications may contribute to metabolic dysfunction.
This bidirectional relationship is central to the 2026 Nature Mental Health review.
2. Why Is Psychiatry Becoming Interested in Metabolism?
One major reason is the substantial burden of cardiometabolic disease among individuals experiencing serious mental illness.
Conditions such as schizophrenia and bipolar disorder are associated with elevated rates of metabolic abnormalities and premature mortality.
Contributing factors can include medication effects, reduced physical activity, smoking, socioeconomic circumstances, sleep disruption, healthcare access, and underlying biological vulnerabilities.
Certain psychiatric medications can produce significant increases in body weight and disturbances in glucose or lipid metabolism.
At the same time, metabolic abnormalities may be present before treatment in some individuals.
These findings raise questions about whether metabolic dysfunction is solely a consequence of psychiatric illness and treatment or whether it also contributes to certain disease processes.
Another reason is the biological complexity of psychiatric disorders.
Individuals receiving the same diagnosis can differ substantially in symptoms, physiological characteristics, and treatment responses.
Researchers are therefore investigating whether metabolic measurements might eventually help identify clinically meaningful subgroups.
For example, some individuals with depression may demonstrate insulin resistance or inflammatory abnormalities.
Others may not.
Determining whether such differences predict prognosis or treatment response could contribute to more personalized care.
However, the presence of a metabolic abnormality does not automatically mean that it caused the psychiatric symptoms.
This distinction remains essential.
3. The Brain Is an Energy-Dependent Organ
The brain is among the body's most metabolically demanding organs.
Despite accounting for only a small percentage of total body mass, it consumes a substantial proportion of the body's energy.
This energy supports numerous processes, including neuronal membrane potentials, electrical signaling, neurotransmitter recycling, synaptic activity, and the maintenance of cellular structures.
Neurons must continuously regulate ion concentrations across their membranes.
This requires considerable energy because electrical signaling depends on maintaining carefully controlled electrochemical gradients.
The brain also requires energy to support communication among neurons and the activity of glial cells.
Consequently, adequate energy availability and efficient cellular metabolism are essential for normal neurological function.
Why Energy Metabolism Matters
Researchers have proposed that disturbances in cerebral energy metabolism may contribute to certain neurological and psychiatric processes.
A 2026 article in Neuropsychopharmacology, Imaging Brain Energetics to Advance Metabolic Psychiatry, discusses growing evidence from neuroimaging, genetics, cellular studies, and molecular research implicating altered brain energy metabolism in neuropsychiatric conditions.
The authors describe interest in changes involving oxidative phosphorylation and glycolysis.
However, identifying metabolic differences among patient populations does not necessarily establish whether these changes cause symptoms, develop in response to disease, or reflect adaptive compensation.
Furthermore, the brain uses multiple energy-related pathways, and their relative contributions vary according to cell type and physiological conditions.
The goal of this research is to understand how these pathways interact with neurological function and whether they provide useful therapeutic targets.
4. Mitochondria: The Relationship Between Cellular Energy and Brain Function
Mitochondria are intracellular organelles involved in energy production, calcium regulation, cellular signaling, and several other biological processes.
Through oxidative phosphorylation, mitochondria generate much of the ATP required for cellular activity.
ATP serves as a major energy currency supporting biological work.
Because neurons have substantial energetic demands, mitochondrial function is particularly relevant to neuroscience.
Mitochondria help support the energy-intensive processes involved in maintaining membrane potentials, releasing neurotransmitters, and sustaining synaptic function.
They also participate in cellular responses to oxidative stress and other physiological challenges.
The 2026 Nature Mental Health review discusses mitochondrial dysfunction as one proposed pathway connecting metabolic abnormalities and psychiatric illness.
Researchers have identified mitochondrial differences in several experimental and clinical contexts.
However, these findings are heterogeneous.
Mitochondrial function cannot currently be reduced to a single laboratory measurement capable of diagnosing most psychiatric disorders.
Nor does evidence of mitochondrial involvement establish that commercially available mitochondrial supplements can effectively treat psychiatric illness.
The clinical relevance of a mitochondrial measurement depends on the specific condition, the reliability of the test, and whether the result informs a validated intervention.
Nevertheless, mitochondrial research provides a valuable framework for investigating relationships among cellular energetics, neurological signaling, and metabolic health.
5. Insulin Resistance: More Than a Blood Sugar Problem
Insulin is best known for its role in glucose regulation.
However, insulin signaling also participates in processes involving cellular metabolism, growth, and energy regulation.
Insulin resistance occurs when tissues demonstrate a reduced biological response to insulin.
It commonly develops in association with factors such as excess visceral adiposity, physical inactivity, genetic susceptibility, sleep disturbances, and other metabolic influences.
Insulin resistance can contribute to elevated blood glucose and increased risk of type 2 diabetes.
However, researchers are also investigating its associations with brain function and mental health.
The 2026 Nature Mental Health review identifies insulin resistance as an important area of metabolic psychiatry research.
Several studies have found associations between insulin resistance and psychiatric outcomes.
Some investigations suggest that metabolic abnormalities may be particularly relevant to specific patient subgroups.
However, insulin resistance does not explain every presentation of depression, bipolar disorder, or schizophrenia.
Nor is it appropriate to assume that psychiatric symptoms indicate an underlying glucose-regulation problem.
The brain's glucose uptake also differs from that of tissues such as skeletal muscle, so systemic insulin resistance should not automatically be interpreted as impaired neuronal glucose availability.
The broader significance is that glucose regulation and mental health may interact through overlapping metabolic, inflammatory, vascular, and signaling pathways.
Understanding these relationships could eventually improve clinical assessment and treatment selection.
6. Lipid Metabolism: Why Fats Matter for the Nervous System
Lipids perform essential biological functions throughout the body.
They contribute to cellular membranes, energy storage, hormone synthesis, and signaling pathways.
Within the nervous system, lipids are particularly important for membrane structure, myelin, and cellular communication.
However, lipid metabolism also contributes to cardiometabolic risk.
Abnormalities involving triglycerides, cholesterol-containing lipoproteins, and other lipid measurements may indicate metabolic dysfunction.
The relationship between psychiatric illness and lipid metabolism is complex.
Certain psychiatric medications can influence body weight, triglycerides, and other cardiometabolic markers.
Dietary patterns, physical activity, genetics, and other conditions also contribute.
Researchers are investigating whether lipid-related measurements may provide additional information about biological differences among psychiatric populations.
However, routine blood lipid measurements cannot currently diagnose psychiatric disorders.
Nor does improving cholesterol automatically establish an improvement in psychiatric symptoms.
The strongest established clinical rationale for monitoring lipid health in psychiatric populations is the prevention and management of cardiovascular and metabolic disease.
This remains important regardless of whether future research identifies more direct psychiatric applications.
7. Inflammation: Understanding the Relationship Between Immunity and Mental Health
The immune and nervous systems communicate through multiple signaling pathways.
Immune mediators can influence neural function, while the nervous system regulates aspects of immune activity through endocrine and autonomic mechanisms.
Inflammatory signaling is necessary for normal immune defense and tissue repair.
However, persistent or dysregulated inflammation may contribute to various disease processes.
Researchers have identified associations between inflammatory markers and certain psychiatric conditions.
For example, some studies of depression have found elevated inflammatory measurements in subsets of participants.
However, these findings vary considerably across individuals.
The 2026 metabolic psychiatry review includes inflammation among the biological processes potentially linking metabolic dysfunction with mental health.
One proposed mechanism involves the interaction between obesity-associated inflammation, altered metabolic regulation, and central nervous system signaling.
Other potential pathways involve immune mediators influencing neurotransmitter metabolism, cellular energetics, or neural plasticity.
Nevertheless, an elevated inflammatory marker is not a psychiatric diagnosis.
Markers such as C-reactive protein or selected cytokines are nonspecific and can be influenced by infections, chronic medical conditions, adiposity, medications, and numerous other factors.
The evidence does not support assuming that reducing inflammation through any particular supplement or intervention will reliably resolve a psychiatric disorder.
Instead, this research suggests that inflammatory biology may contribute to clinically meaningful differences among some patients.
8. Stress, Allostatic Load, and Metabolic Dysfunction
Metabolic psychiatry also connects with the broader science of stress physiology.
Stress responses involve coordinated changes across the nervous, endocrine, cardiovascular, immune, and metabolic systems.
During an acute challenge, these changes can help the body mobilize energy and respond to immediate demands.
For example, sympathetic activation and stress-related hormonal signaling can influence glucose availability, cardiovascular function, and other physiological processes.
These responses are not inherently harmful.
They are essential components of adaptation.
However, repeated or persistent demands may contribute to changes in sleep, eating behavior, physical activity, and metabolic regulation.
The concept of allostatic load describes the cumulative physiological consequences associated with repeated or chronic adaptation to stressors.
The 2026 Nature Mental Health review discusses allostatic load as one theoretical framework for understanding metabolic and psychiatric interactions.
Within this framework, psychological stress and metabolic dysfunction may reinforce one another through several pathways.
For example, persistent stress may interfere with sleep.
Sleep disruption can contribute to impaired glucose regulation and changes in appetite.
These metabolic changes may coexist with fatigue, reduced activity, and psychological distress.
The resulting pattern can create additional challenges for recovery.
However, not every stress-related metabolic change represents disease.
The relevance depends on duration, severity, individual vulnerability, and the broader clinical context.
9. The Selfish Brain Hypothesis: How the Brain Prioritizes Energy
Another theoretical model discussed in metabolic psychiatry is the selfish brain hypothesis.
This framework proposes that the brain plays an active role in regulating energy allocation to protect its substantial metabolic requirements.
Rather than functioning as a passive recipient of circulating nutrients, the central nervous system participates in processes influencing appetite, glucose regulation, autonomic activity, and energy availability.
The model has been used to explore relationships among stress, body weight, and metabolic regulation.
It provides a conceptual explanation for why brain energy demands and systemic metabolism may interact.
However, it remains a theoretical framework rather than a complete explanation for psychiatric illness.
It does not establish that all psychiatric symptoms arise from insufficient brain energy.
Nor does it prove that increasing energy availability or following one particular dietary strategy will correct psychiatric dysfunction.
Its value lies in encouraging researchers to examine energy regulation as a dynamic process involving the brain and body together.
10. Why Mental Illness and Metabolic Dysfunction Can Reinforce One Another
The relationship between psychiatric conditions and metabolic health is often bidirectional.
Consider someone experiencing persistent depression.
Reduced motivation and fatigue may make physical activity more difficult.
Sleep disturbances may interfere with appetite regulation and daily routines.
Changes in food choices, activity, and sleep may subsequently influence metabolic health.
Some psychiatric medications may also contribute to weight gain or glucose dysregulation.
Over time, worsening metabolic health may contribute additional fatigue, physical discomfort, or reduced quality of life.
These changes can make psychological recovery more challenging.
However, the sequence may also operate in the opposite direction.
Individuals with chronic metabolic disease may experience psychological distress related to symptom burden, medication management, financial costs, or limitations in daily functioning.
This illustrates why treating mental and metabolic health as entirely separate concerns can leave important patient needs unaddressed.
A comprehensive approach recognizes both directions while avoiding the assumption that every psychiatric condition has a metabolic cause.
11. Nutritional Psychiatry and Metabolic Psychiatry: How Are They Different?
Nutritional psychiatry investigates relationships between dietary patterns, nutrient intake, and mental health.
Metabolic psychiatry encompasses a broader range of biological processes.
It includes nutrition, but also examines insulin signaling, mitochondrial function, lipid regulation, metabolic medications, inflammation, and central nervous system energetics.
For example, researchers studying nutritional psychiatry may investigate whether a Mediterranean-style dietary intervention improves depressive symptoms.
Researchers studying metabolic psychiatry may additionally investigate whether changes in insulin resistance or other physiological characteristics influence treatment response.
The fields therefore overlap but are not identical.
Both recognize that nutrition can influence the physiological environment in which the brain operates.
However, neither framework establishes that diet alone is a substitute for evidence-based psychiatric treatment.
12. The Ketogenic Diet: A Promising but Still Experimental Area
One of the most widely discussed interventions in metabolic psychiatry is ketogenic metabolic therapy.
A ketogenic diet substantially restricts carbohydrate intake to increase the production of ketone bodies.
Ketone bodies can serve as an alternative energy substrate for the brain and other tissues under certain physiological conditions.
Ketogenic diets have an established medical role in selected forms of epilepsy.
This history has encouraged researchers to investigate whether metabolic changes associated with ketosis might also influence psychiatric symptoms.
Proposed mechanisms include changes in cellular energetics, neurotransmission, mitochondrial function, and inflammatory signaling.
However, demonstrating biological plausibility is different from establishing clinical effectiveness.
What Do Recent Trials Show?
A 2025 pilot study published in Translational Psychiatry examined a ketogenic dietary intervention among 24 college students with major depressive disorder.
Participants continued their existing standard care, which could include counseling or medication.
The intervention lasted approximately 10–12 weeks and included dietary guidance and metabolic monitoring.
The study reported improvements in depressive symptoms and selected metabolic outcomes.
However, because it did not include a randomized control group, researchers could not establish whether improvements were specifically caused by the ketogenic diet.
Other influences may have contributed, including concurrent treatment, additional support, changes in daily routines, or natural symptom variation.
A larger 2026 systematic review and meta-analysis in Translational Psychiatry examined ketogenic interventions across serious mental illness and neurocognitive disorders.
The review included 73 studies.
The authors found encouraging observations but emphasized that evidence involving serious mental illness relied heavily on case reports and uncontrolled trials.
The more robust controlled evidence involved modest improvements in cognitive performance among participants with neurocognitive disorders.
However, heterogeneity remained substantial.
These findings support further research rather than routine adoption of ketogenic diets as established psychiatric treatment.
Why Safety Matters
Ketogenic diets are not suitable for everyone.
They can affect medication requirements, gastrointestinal function, lipid measurements, and nutritional adequacy.
Additional concerns arise in individuals with certain metabolic disorders, eating disorders, pregnancy-related considerations, or medications that increase the risk of hypoglycemia or ketoacidosis.
In psychiatric populations, abrupt dietary changes may also interact with medication management and existing medical conditions.
For these reasons, ketogenic metabolic therapy for psychiatric conditions should be considered an emerging adjunctive intervention requiring appropriate medical oversight.
It should not replace prescribed psychiatric medication or psychological treatment.
13. Physical Activity: One of the More Established Connections
Physical activity provides a particularly important intersection between metabolic health and mental well-being.
Exercise influences glucose regulation, cardiovascular fitness, skeletal muscle function, and body composition.
It also affects sleep, cognition, mood, and quality of life.
Compared with many emerging metabolic psychiatry interventions, exercise has a larger and more established evidence base as an adjunctive component of mental healthcare.
For example, a 2025 meta-review published in World Psychiatry examined the effectiveness, mechanisms, and implementation of physical activity across mental disorders.
The authors found support for exercise as an adjunctive intervention in several psychiatric populations.
However, the magnitude of benefit varies according to diagnosis, exercise characteristics, and study design.
Exercise does not eliminate the need for established medical or psychological treatment when those interventions are indicated.
Nevertheless, it offers an example of how interventions supporting metabolic health can also contribute to psychological well-being.
Its broader benefits include improved physical capacity, cardiovascular health, and functional independence.
14. Can Metabolic Medications Improve Mental Health Outcomes?
Researchers are also investigating medications that influence metabolic pathways.
The 2026 Nature Mental Health review discusses several examples, including metformin, glucagon-like peptide-1 receptor agonists, and pioglitazone.
Metformin
Metformin is commonly used in diabetes management.
It is also used in selected clinical circumstances to address antipsychotic-associated weight gain and metabolic abnormalities.
Researchers have investigated whether it may have additional effects on psychiatric or cognitive outcomes.
However, its established metabolic benefits should not be confused with proven efficacy as a primary psychiatric treatment.
GLP-1 Receptor Agonists
GLP-1 receptor agonists influence glucose regulation, appetite, and other physiological processes.
They have attracted growing interest because of their metabolic effects and possible neurological applications.
However, psychiatric benefits remain under investigation.
They should not be described as established treatments for depression, bipolar disorder, or schizophrenia without appropriate supporting evidence.
Pioglitazone
Pioglitazone is an insulin-sensitizing medication.
Researchers have examined whether modifying insulin-related pathways might influence symptoms in certain psychiatric conditions.
Existing studies are relatively limited and have produced mixed findings.
The broader scientific question is whether individuals with specific metabolic characteristics might respond differently to metabolism-targeting interventions.
This remains an active area of research.
Medication decisions should be made by appropriately licensed prescribing clinicians.
15. The Gut–Brain Axis: Metabolism, Microbial Signaling, and Mental Health
The gastrointestinal system and nervous system communicate through neural, endocrine, immune, and metabolic pathways.
Gut microorganisms produce metabolites that can interact with host physiology.
These include short-chain fatty acids, bile acid derivatives, and compounds involved in amino acid metabolism.
Researchers have proposed that some of these molecules may influence pathways relevant to brain function.
However, understanding whether microbiome differences contribute to psychiatric disorders remains challenging.
A 2025 review in Nature Mental Health, Distinguishing the Causative, Correlative and Bidirectional Roles of the Gut Microbiota in Mental Health, critically examines these relationships.
The authors emphasize that microbiome differences associated with psychiatric conditions do not automatically establish causality.
Diet, medications, stress, sleep, and other factors can influence microbial composition.
Psychiatric symptoms may also affect eating patterns and other behaviors that subsequently influence the microbiome.
A 2026 review in Translational Psychiatry similarly concludes that many proposed gut–brain mechanisms are biologically plausible, but stronger causal evidence is needed before most microbiome-targeted interventions can be considered established psychiatric treatments.
These findings illustrate a central challenge within metabolic psychiatry.
A biological association becomes clinically useful only when research establishes how it relates to outcomes and whether modifying it produces meaningful benefits.
16. Metabolic Screening: An Important Opportunity for Integrated Care
One of the clearest practical implications of metabolic psychiatry involves identifying and managing metabolic health risks among individuals receiving psychiatric care.
This is especially important for patients taking medications known to influence weight, glucose regulation, or lipid metabolism.
Depending on clinical circumstances, appropriate monitoring may include weight, waist circumference, blood pressure, glucose-related measurements, and lipid profiles.
Such assessment helps identify cardiovascular and metabolic risk factors that deserve treatment.
However, metabolic screening should not be confused with diagnosing psychiatric disease.
For example, elevated fasting insulin may provide information relevant to metabolic regulation, but it does not establish a diagnosis of depression or bipolar disorder.
Similarly, an elevated inflammatory marker does not demonstrate that psychiatric symptoms arise from inflammation.
The purpose of testing is to answer clinically meaningful questions and guide appropriate care.
When abnormalities are identified, management may involve nutrition, physical activity, medication review, medical treatment, or other interventions according to established indications.
This is one area in which improved collaboration between psychiatric and general healthcare services may provide substantial benefits.
17. Why Metabolic Psychiatry Is Moving Toward Personalized Care
Metabolic psychiatry shares several principles with the broader development of precision healthcare.
One is the recognition that individuals with similar symptoms may have different contributing factors.
Another is the importance of considering multiple physiological systems rather than focusing exclusively on one biological pathway.
A third is that interventions should ideally be selected according to characteristics that predict meaningful benefit.
For example, researchers may eventually identify specific metabolic profiles associated with improved responses to particular interventions.
However, this remains a research objective.
Current evidence does not justify using unvalidated laboratory panels to classify individuals into psychiatric metabolic subtypes or prescribe specialized diets as psychiatric treatment.
The 2025 Nature Mental Health commentary highlights the importance of rigorous research, inclusion of diverse populations, transparency, and the perspectives of individuals with lived experience.
These priorities matter because findings from narrow or highly selected samples may not apply to the broader population.
The ultimate goal should not be increasingly elaborate testing.
It should be better outcomes, safer treatment, and more equitable healthcare.
18. What Can We Learn From Metabolic Psychiatry Outside the Field of Psychiatry?
Although metabolic psychiatry is a specialized medical and scientific field, several of its underlying principles have relevance across healthcare.
The first is that organ systems do not function independently.
Brain function depends on energy regulation, circulation, and interactions with endocrine and immune processes.
The second is that psychological experiences and physiological regulation can influence each other.
For example, poor sleep may contribute to metabolic dysfunction, while chronic illness may contribute to emotional distress.
The third is that lifestyle interventions can influence multiple dimensions of health.
Nutrition, physical activity, sleep, and stress management may support metabolic well-being and psychological functioning, even when they do not directly treat a psychiatric disorder.
Finally, metabolic psychiatry reinforces the importance of interdisciplinary care.
Complex symptoms may warrant contributions from multiple appropriately qualified professionals.
The broader lesson is that understanding an individual's health requires considering biological, psychological, behavioral, and environmental factors together.
19. How This Research Informs Our Philosophy
We recognize that mental and metabolic health are interconnected dimensions of whole-person well-being. Our approach to comprehensive wellness considers how nutrition, movement, sleep, stress, and other lifestyle factors contribute to physiological function.
The emerging field of metabolic psychiatry reinforces the value of understanding these interactions.
Within our Eat Well services, we emphasize education concerning nutritional adequacy, dietary patterns, metabolic health, and sustainable eating behaviors.
Our Move Well services support physical activity, exercise participation, functional movement, and the development of physical capacity.
Our Sleep Well and Stress Well programs address lifestyle factors that can influence recovery, physiological regulation, and everyday functioning.
When appropriate, metabolic evaluation may help identify concerns such as dysglycemia, lipid abnormalities, or nutrient deficiencies that warrant management or referral.
However, these findings should be interpreted according to established clinical standards.
We do not claim that metabolic testing diagnoses psychiatric conditions or that individualized nutritional interventions replace psychiatric treatment.
Nor do we present ketogenic metabolic therapy, supplements, or other emerging interventions as proven treatments for serious mental illness.
Individuals experiencing psychiatric symptoms may require assessment and treatment from appropriately licensed mental health professionals.
Our role is to support relevant aspects of physical health, lifestyle education, and wellness while collaborating with other healthcare professionals when appropriate.
This approach recognizes that a person receiving psychiatric care may also benefit from attention to metabolic health without implying that metabolic care can replace psychiatric management.
Conclusion: Understanding Mental Health Within the Metabolism of the Whole Body
Metabolic psychiatry represents an important development in the scientific investigation of mental health.
For many years, metabolic and psychiatric conditions have often been studied and managed through separate clinical frameworks.
Contemporary research increasingly demonstrates that energy metabolism, glucose regulation, inflammatory signaling, mitochondrial function, and other physiological processes may interact with mental health.
Some relationships are well established.
For example, metabolic disease is common among individuals with serious mental illness, and certain psychiatric medications can produce substantial metabolic side effects.
Physical activity and appropriate cardiometabolic care also provide meaningful health benefits.
Other relationships remain under investigation.
These include whether particular metabolic abnormalities contribute directly to psychiatric symptoms and whether interventions such as ketogenic diets or metabolic medications can improve psychiatric outcomes in clearly defined patient populations.
The distinction between established evidence and emerging hypotheses is essential.
Metabolic psychiatry does not demonstrate that every mental health condition is caused by metabolic dysfunction.
Rather, it challenges researchers to investigate the complex, bidirectional relationships between brain function and whole-body physiology.
The future of metabolic psychiatry may depend less on discovering one universal metabolic cause of mental illness and more on identifying which biological mechanisms matter for which individuals—and how that information can improve appropriately personalized care.
We believe the broader lesson is highly relevant:
The brain does not function independently of the body, and the body does not function independently of the environment in which it lives, or the community it socializes with.
Understanding these relationships offers a more comprehensive foundation for supporting metabolic health, physical well-being, and the lifestyle factors that contribute to long-term human function.
Research References
Sethi S, Berk M, Andreazza AC, et al. Metabolic psychiatry targeting metabolic dysregulation in mental health. Nature Mental Health. 2026;4:508–520. https://doi.org/10.1038/s44220-026-00609-5
Mudra Rakshasa-Loots A, Campbell J, Campbell IH, Smith DJ. Metabolic psychiatry: key priorities for an emerging field. Nature Mental Health. 2025;3:855–858. https://doi.org/10.1038/s44220-025-00445-z
Gaggi NL, Liebers DT. Imaging brain energetics to advance metabolic psychiatry. Neuropsychopharmacology. 2026;51:715–717. https://doi.org/10.1038/s41386-025-02304-y
Maksyutynska K, Arnold C, De R, et al. The efficacy of ketogenic interventions on neuropsychological and metabolic outcomes in serious mental illness and neurocognitive disorders: a systematic review and meta-analysis. Translational Psychiatry. Published August 27, 2026. https://doi.org/10.1038/s41398-026-04370-2
Decker DD, Patel R, Cheavens J, et al. A pilot study examining a ketogenic diet as an adjunct therapy in college students with major depressive disorder. Translational Psychiatry. 2025;15:322. https://doi.org/10.1038/s41398-025-03544-8
Kamath S, Sokolenko E, Clark SR, et al. Distinguishing the causative, correlative and bidirectional roles of the gut microbiota in mental health. Nature Mental Health. 2025;3:1137–1151. https://doi.org/10.1038/s44220-025-00498-0
Almarzooqi S, Yassin LK, Alnuaimi F, et al. From association to causality: mechanistic pathways linking the gut microbiome to psychiatric disorders. Translational Psychiatry. 2026;16:561. https://doi.org/10.1038/s41398-026-04305-x
Pereira S, Hahn MK. GLP-2 attenuates antipsychotics' adverse metabolic effects. Nature Metabolism. 2025;7:637–638. https://doi.org/10.1038/s42255-025-01248-3
Sethi S, et al. Ketogenic diet intervention on metabolic and psychiatric health in bipolar disorder and schizophrenia: a pilot trial. Psychiatry Research. 2024;335:115866.
Vancampfort D, et al. The efficacy, mechanisms and implementation of physical activity as an adjunctive treatment in mental disorders: a meta-review of outcomes, neurobiology and key determinants. World Psychiatry. 2025;24:227–239.
Marx W, et al. Clinical guidelines for the use of lifestyle-based mental health care in major depressive disorder: World Federation of Societies for Biological Psychiatry and Australasian Society of Lifestyle Medicine taskforce. World Journal of Biological Psychiatry. 2023;24:333–386.
Firth J, et al. A meta-review of lifestyle psychiatry: the role of exercise, smoking, diet and sleep in the prevention and treatment of mental disorders. World Psychiatry. 2020;19:360–380.